Journal
NATURE BIOTECHNOLOGY
Volume 18, Issue 4, Pages 405-409Publisher
NATURE AMERICA INC
DOI: 10.1038/74455
Keywords
adoptive cell therapy; CD8(+) T cell; costimulation; dendritic cells; immunotherapy; retrovirus-mediated gene transfer
Categories
Funding
- NCI NIH HHS [CA-59350] Funding Source: Medline
Ask authors/readers for more resources
The adoptive transfer of antigen-specific cytotoxic T lymphocytes (CTLs) is a promising therapeutic approach for a number of diseases. To overcome the difficulty in generating specific CTLs, we established stable artificial antigen-presenting cells (AAPCs) that can be used to stimulate T cells of any patient of a given human leukocyte antigen (HLA) type. Mouse fibroblasts were retrovirally transduced with a single HLA-peptide complex along with the human accessory molecules B7.1, ICAM-1, and LFA-3. These AAPCs consistently elicit strong stimulation and expansion of HLA-restricted CTLs. Owing to the high efficiency of retrovirus-mediated gene transfer, stable AAPCs can be readily engineered for any HLA molecule and any specific peptide.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available